Efficacy of adjuvant chemotherapy after surgery when considered over all cancer types: A synthesis of meta-analyses

Annals of Surgical Oncology

Volumn 19, Issue 11, 2012, Pages 3343-3350

  Bowater, Russell J ^a   Abdelmalik, Sally M E ^b   Lilford, Richard J ^b  

^a DEPARTAMENTO DE QUÍMICA   (Mexico)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL;

ARTICLE; CANCER ADJUVANT THERAPY; CANCER MORTALITY; CANCER SURGERY; CLINICAL TRIAL; COLORECTAL CANCER; DISEASE CLASSIFICATION; DRUG EFFICACY; HUMAN; META ANALYSIS; METASTASIS; SYSTEMATIC REVIEW;

CHEMOTHERAPY, ADJUVANT; CONFIDENCE INTERVALS; HUMANS; NEOPLASMS; RISK; SURVIVAL ANALYSIS;

EID: 84868202126     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-012-2388-1     Document Type: Article

References (23)

1. Weissman DE, von Gunten CF. Fast Fact and Concept #99. Chemotherapy: Response and survival data. 2nd edn. November 2007. End-of-Life/Palliative Education Resource Center (www.eperc.mcw.edu).
2. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177-88. (Pubitemid 17189972)
3. Early Breast Cancer Trialists' Collaborative Group (EBCTCG). Adjuvant chemotherapy in oestrogen-receptor-poor breast cancer: Patient-level meta-analysis of randomised trials. Lancet. 2008; 371(9606):29-40.
4. Early Breast Cancer Trialists' Collaborative Group (EBCTCG). Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: An overview of the randomised trials. Lancet. 2005;365(9472):1687-717.
5. Noguchi S, Koyama H, Uchino J, Abe R, Miura S, Sugimachi K, et al. Postoperative adjuvant therapy with tamoxifen, tegafur plus uracil, or both in women with node-negative breast cancer: A pooled analysis of six randomized controlled trials. J Clin Oncol. 2005;23(10):2172-84. (Pubitemid 46218709)
6. Gill S, Loprinzi CL, Sargent DJ, Thomé SD, Alberts SR, Haller DG, et al. Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: Who benefits and by how much? J Clin Oncol. 2004;22(10):1797-806. (Pubitemid 41095169)
7. Sakamoto J, Hamada C, Rahman M, Kodaira S, Ito K, Nakazato H, et al. An individual patient data meta-analysis of adjuvant therapy with carmofur in patients with curatively resected colon cancer. Jpn J Clin Oncol. 2005;35(9):536-44. (Pubitemid 41573944)
8. Sakamoto J, Hamada C, Yoshida S, Kodaira S, Yasutomi M, Kato T, et al. An individual patient data meta-analysis of adjuvant therapy with uracil-tegafur (UFT) in patients with curatively resected rectal cancer. Br J Cancer. 2007;96(8):1170-7. (Pubitemid 46625067)
9. Zhao SL, Fang JY. The role of postoperative adjuvant chemotherapy following curative resection for gastric cancer: A metaanalysis. Cancer Invest. 2008;26(3):317-25.
10. Mathurin P, Raynard B, Dharancy S, Kirzin S, Fallik D, Pruvot FR, et al. Meta-analysis: Evaluation of adjuvant therapy after curative liver resection for hepatocellular carcinoma. Aliment Pharmacol Ther. 2003;17(10):1247-61. (Pubitemid 36693726)
11. Stocken DD, Büchler MW, Dervenis C, Bassi C, Jeekel H, Klinkenbijl JH, et al. Meta-analysis of randomised adjuvant therapy trials for pancreatic cancer. Br J Cancer. 2005;92(8):1372-81. (Pubitemid 40705002)
12. Malthaner RA, Wong RK, Rumble RB, Zuraw L. Neoadjuvant or adjuvant therapy for resectable esophageal cancer: A systematic review and meta-analysis. BMC Med. 2004;2(35).
13. Winquist E, Oliver T, Gilbert R. Postoperative chemoradiotherapy for advanced squamous cell carcinoma of the head and neck: A systematic review with meta-analysis. Head Neck. 2007; 29(1):38-46. (Pubitemid 46032565)
14. Pignon JP, Tribodet H, Scagliotti GV, Douillard JY, Shepherd FA, Stephens RJ, et al. Lung adjuvant cisplatin evaluation: A pooled analysis by the LACE collaborative group. J Clin Oncol. 2008;26(21):3552-9.
15. Hamada C, Tanaka F, Ohta M, Fujimura S, Kodama K, Imaizumi M, et al. Meta-analysis of postoperative adjuvant chemotherapy with tegafur-uracil in non-small-cell lung cancer. J Clin Oncol. 2005;23(22):4999-5006. (Pubitemid 46224006)
16. Advanced Bladder Cancer (ABC) Meta-analysis Collaboration. Adjuvant chemotherapy in invasive bladder cancer: A systematic review and meta-analysis of individual patient data. Eur Urol. 2005;48(2):189-99.
17. Elit L, Chambers A, Fyles A, Covens A, Carey M, Fung MF. Systematic review of adjuvant care for women with stage I ovarian carcinoma. Cancer. 2004;101(9):1926-35. (Pubitemid 39425367)
18. Stewart L, Burdett S, Glioma Meta-analysis Trialists (GMT) Group. Chemotherapy for high-grade glioma. Cochrane Database Syst Rev. 2002;(3):CD003913.
19. Verma S, Quirt I, McCready D, Bak K, Charette M, Iscoe N. Systematic review of systemic adjuvant therapy for patients at high risk for recurrent melanoma. Cancer. 2006;106(7):1431-42.
20. Sarcoma Meta-analysis Collaboration. Adjuvant chemotherapy for localised resectable soft-tissue sarcoma of adults: Meta-analysis of individual data. Lancet. 1997;350(9092):1647-54.
21. Nelson R, Freels S. Hepatic artery adjuvant chemotherapy for patients having resection or ablation of colorectal cancer metastatic to the liver. Cochrane Database Syst Rev. 2006;(4): CD003770.
22. Higgins JPT, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539-58. (Pubitemid 34746062)
23. Portier G, Elias D, Bouche O, Rougier P, Bosset J-F, Saric J, et al. Multicenter randomized trial of adjuvant fluorouracil and folinic acid compared with surgery alone after resection of colorectal liver metastases: FFCD ACHBTH AURC 9002 trial. J Clin Oncol. 2006;24(31):4976-82. (Pubitemid 46631399)